keyword
MENU ▼
Read by QxMD icon Read
search

Mascc

keyword
https://www.readbyqxmd.com/read/27900562/special-section-mascc-esmo-antiemetic-guidelines-special-guest-editors-alex-molasiotis-matti-aapro-jorn-herrstedt-richard-gralla-fausto-roila
#1
(no author information available yet)
No abstract text is available yet for this article.
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27853930/a-systematic-review-of-oral-herpetic-viral-infections-in-cancer-patients-commonly-used-outcome-measures-and-interventions
#2
Sharon Elad, Vinisha Ranna, Anura Ariyawardana, Maria Elvira Pizzigatti Correa, Vanessa Tilly, Raj G Nair, Tanya Rouleau, Richard M Logan, Andres Pinto, Veronica Charette, Debbie P Saunders, Siri Beier Jensen
PURPOSE: To review the literature for outcome measures for oral viral infections in cancer patients. A secondary aim was to update the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) clinical practice guidelines for the management of oral viral infections in cancer patients. METHODS: Databases were searched for articles published in the English language, 1981-2013. Studies that met the eligibility criteria were reviewed systematically...
November 16, 2016: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27815710/2016-updated-mascc-esmo-consensus-recommendations-prevention-of-nausea-and-vomiting-following-multiple-day-chemotherapy-high-dose-chemotherapy-and-breakthrough-nausea-and-vomiting
#3
Lawrence H Einhorn, Bernardo Rapoport, Rudolph M Navari, Jørn Herrstedt, Mary J Brames
PURPOSE: This review summarizes the recommendations for the prophylaxis of acute and delayed nausea and vomiting induced by multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting as agreed at the MASCC/ESMO Antiemetic Guidelines update meeting in Copenhagen in June 2015. METHODS: A systematic literature search using PubMed from January 01, 2009 through January 06, 2015 with a restriction to papers in English was conducted. RESULTS: There were three phase III randomized trials in patients undergoing high-dose chemotherapy and stem cell transplant and eight single arm non-randomized clinical studies (single in patients undergoing transplantation and one in patients receiving multiple-day chemotherapy treatment)...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27796777/impact-of-adherence-to-antiemetic-guidelines-on-the-incidence-of-chemotherapy-induced-nausea-and-vomiting-and-quality-of-life
#4
Nibal Abunahlah, Mesut Sancar, Faysal Dane, Mustafa Kerem Özyavuz
Background International guidelines are tools enabling physicians to incorporate the latest evidence based clinical information into practice. Objective This study aimed to evaluate the impact of antiemetic guidelines adherence on the incidence of chemotherapy-induced nausea and vomiting (CINV) and patient quality of life. Setting Marmara University Pendik Training and Research Hospital chemotherapy unit, Istanbul, Turkey. Method The study included 100 chemotherapy naive patients. Antiemetic prescribing patterns and their consistency with MASCC/ESMO 2014 guidelines were assessed...
December 2016: International Journal of Clinical Pharmacy
https://www.readbyqxmd.com/read/27664248/2016-mascc-and-esmo-guideline-update-for-the-prevention-of-chemotherapy-and-radiotherapy-induced-nausea-and-vomiting-and-of-nausea-and-vomiting-in-advanced-cancer-patients
#5
F Roila, A Molassiotis, J Herrstedt, M Aapro, R J Gralla, E Bruera, R A Clark-Snow, L L Dupuis, L H Einhorn, P Feyer, P J Hesketh, K Jordan, I Olver, B L Rapoport, J Roscoe, C H Ruhlmann, D Walsh, D Warr, M van der Wetering
No abstract text is available yet for this article.
September 2016: Annals of Oncology: Official Journal of the European Society for Medical Oncology
https://www.readbyqxmd.com/read/27624467/erratum-to-2016-updated-mascc-esmo-consensus-recommendations-prevention-of-nausea-and-vomiting-following-moderately-emetogenic-chemotherapy
#6
Fausto Roila, David Warr, Paul J Hesketh, Richard Gralla, Jorn Herrstedt, Karin Jordan, Matti Aapro, Enzo Ballatori, Bernardo Rapoport
No abstract text is available yet for this article.
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27624464/2016-updated-mascc-esmo-consensus-recommendations-prevention-of-radiotherapy-induced-nausea-and-vomiting
#7
Christina H Ruhlmann, Franziska Jahn, Karin Jordan, Kristopher Dennis, Ernesto Maranzano, Alexander Molassiotis, Fausto Roila, Petra Feyer
PURPOSE: Radiotherapy-induced nausea and vomiting (RINV) are distressing symptoms. Evidence-based guidelines should facilitate the prescription of the best possible antiemetic prophylaxis. As part of the MASCC/ESMO Antiemetic Guidelines Update 2016, a thorough review of the literature concerning RINV since the 2009 update was required. METHODS: A systematic review of the literature including data published from June 2009 to May 2015 was performed. Committee VII (RINV) under the MASCC/ESMO Antiemetic Guidelines Update Committee assessed the literature...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27572335/2016-updated-mascc-esmo-consensus-recommendations-controlling-nausea-and-vomiting-with-chemotherapy-of-low-or-minimal-emetic-potential
#8
Ian Olver, Christina H Ruhlmann, Franziska Jahn, Lee Schwartzberg, Bernardo Rapoport, Cynthia N Rittenberg, Rebecca Clark-Snow
PURPOSE: The purpose of this review is to update the MASCC (Multinational Association of Supportive Care in Cancer) guidelines for controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. METHODS: The antiemetic study group of MASCC met in Copenhagen in 2015 to review the MASCC antiemetic guidelines. A subgroup performed a systematic literature review on antiemetics for low emetogenic chemotherapy (LEC) and chemotherapy of minimal emetic potential and the chair presented the update recommendation to the whole group for discussion...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27565788/2016-updated-mascc-esmo-consensus-recommendations-prevention-of-acute-chemotherapy-induced-nausea-and-vomiting-in-children
#9
L Lee Dupuis, Lillian Sung, Alexander Molassiotis, Andrea D Orsey, Wim Tissing, Marianne van de Wetering
PURPOSE: To update the 2009 recommendations for the prevention of acute chemotherapy-induced emesis in children. METHODS: We updated the original systematic literature search. Randomized studies were included in the evidence to support this guideline if they were primary studies fully published in full text in English or French; included only children less than 18 years old or, for mixed studies of adults and children, reported the pediatric results separately or the median or mean age was no more than 13 years; evaluated acute chemotherapy-induced nausea and vomiting (CINV) prophylaxis; provided sufficient information to permit determination of the emetogenicity of the antineoplastic therapy administered or the study investigators stated the emetogenicity of the chemotherapy administered; included an implicit or explicit definition of complete acute CINV response; described the antiemetic regimen in full; and reported the complete acute CINV response rate as a proportion...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27534961/2016-updated-mascc-esmo-consensus-recommendations-management-of-nausea-and-vomiting-in-advanced-cancer
#10
Declan Walsh, Mellar Davis, Carla Ripamonti, Eduardo Bruera, Andrew Davies, Alex Molassiotis
PURPOSE: The aim of this paper is to review the existing literature related to the management of nausea and vomiting (N & V) in advanced cancer and derive clinical evidence-based recommendations for its management. METHODS: Available systematic reviews on antiemetic drug effectiveness were used. One generic systematic review of antiemetics in advanced cancer (to 2009) was updated to February 2016. Agreement on recommendations was reached between panel members, and these were voted in favor unanimously by the larger antiemetic committee membership (n = 37)...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27510316/2016-updated-mascc-esmo-consensus-recommendations-prevention-of-nausea-and-vomiting-following-moderately-emetogenic-chemotherapy
#11
Fausto Roila, David Warr, Paul J Hesketh, Richard Gralla, Jorn Herrstedt, Karin Jordan, Matti Aapro, Enzo Ballatori, Bernardo Rapoport
PURPOSE: An update of the recommendations for the prophylaxis of acute and delayed emesis induced by moderately emetogenic chemotherapy published after the last MASCC/ESMO antiemetic consensus conference in 2009 has been carried out. METHODS: A systematic literature search using PubMed from January 1, 2009 to January 6, 2015 with a restriction to papers in English was conducted. RESULTS: Overall, two randomized phase II and seven randomized phase III studies plus the results of three subgroup analysis of large phase III trials and those of a pilot study have been included...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27510314/2016-updated-mascc-esmo-consensus-recommendations-anticipatory-nausea-and-vomiting-in-children-and-adults-receiving-chemotherapy
#12
L Lee Dupuis, Joseph A Roscoe, Ian Olver, Matti Aapro, Alexander Molassiotis
PURPOSE: We aimed to update the 2011 recommendations for the prevention and treatment of anticipatory nausea and vomiting in children and adults receiving chemotherapy. METHODS: The original systematic literature search was updated. Randomized studies were included in the evidence to support this guideline if they as follows: were primary studies published in a journal in full text (i.e., abstracts, letters, book chapters, and dissertations were excluded); published in English; evaluated an intervention for the prevention or treatment of anticipatory nausea and vomiting; reported the proportion of patients experiencing complete control of anticipatory nausea and vomiting consistently and; included at least ten participants per study arm for comparative studies and at least ten participants overall for noncomparative studies...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27501965/2016-updated-mascc-esmo-consensus-recommendations-emetic-risk-classification-and-evaluation-of-the-emetogenicity-of-antineoplastic-agents
#13
Karin Jordan, Alexandre Chan, Richard J Gralla, Franziska Jahn, Bernardo Rapoport, David Warr, Paul J Hesketh
PURPOSE: Employing the same framework as in previous guideline updates, antineoplastic agents were classified into four emetic risk categories. The classification of the emetogenic level of new antineoplastic agents, especially for the oral drugs, represents an increasing challenge. Accurate reporting of emetogenicity of new antineoplastic agents in the absence of preventive antiemetic treatment is rarely available. METHODS: A systematic search was conducted for drugs approved after 2009 until June 2015 using EMBASE and PubMed...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27501964/mascc-esmo-antiemetic-guidelines-introduction-to-the-2016-guideline-update
#14
A Molassiotis, M Aapro, J Herrstedt, R Gralla, F Roila
No abstract text is available yet for this article.
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27443154/2016-updated-mascc-esmo-consensus-recommendations-prevention-of-nausea-and-vomiting-following-high-emetic-risk-chemotherapy
#15
Jørn Herrstedt, Fausto Roila, David Warr, Luigi Celio, Rudolph M Navari, Paul J Hesketh, Alexandre Chan, Matti S Aapro
PURPOSE: This review summarizes the recommendations for the prophylaxis of nausea and vomiting in adults receiving highly emetogenic chemotherapy (HEC) which includes cisplatin, mechlorethamine, streptozocin, cyclophosphamide >1500 mg/m(2), carmustine, dacarbazine, and the combination of an anthracycline and cyclophosphamide (AC) administered to women with breast cancer, as agreed at the MASCC/ESMO Antiemetic Guidelines Update meeting in Copenhagen in June 2015. METHODS: A systematic review of the literature using PubMed and the Cochrane Database from 2009 to June 2015 was performed...
January 2017: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27181759/-prognosis-prediction-of-febrile-neutropenia-by-mascc-score-a-retrospective-study
#16
Louise Cervetti, Alexis Vallard, Sylvestre Le Moulec, Sophie Espenel, Alexander Tuan Falk, Majed Ben Mrad, Jean-Baptiste Guy, Peng Diao, Benoîte Méry, Julien Langrand-Escure, François-Régis Ferrand, Romain Rivoirard, Bernard Ceccaldi, Lionel Védrine, Nicolas Magné, Cyrus Chargari
INTRODUCTION: The score of the MASCC, by means of clinical criteria, estimates the risk of serious complications in patients with neutropenic fever induced by chemotherapy. METHODS: We retrospectively studied a cohort of patients hospitalized for a neutropenic fever and analyzed complications according to the criteria defined by the MASCC. RESULTS: Eighty-one neutropenic fevers in 71 patients were identified. Microbiological documentation was obtained in 33% of cases only...
June 2016: Bulletin du Cancer
https://www.readbyqxmd.com/read/27178880/-region-wide-professional-practice-evaluation-with-regards-to-antiemetic-prescription-into-chemotherapy-induced-nausea-and-vomiting
#17
Jérôme Tavernier, Mireille Jouannet-Romaszko, Helena Bertucat, Nathalie Marchiset, Mohum Bahadoor, Régine Chevrier
The anticancer drug technical commission (COTECH) of the Auvergne OMEDIT has set up a region-wide professional practice evaluation (PPE) with regards to antiemetic prescription practices in chemotherapy-induced nausea and vomiting (CINV), in order to evaluate their compliance with OMEDIT's guidelines. Are not included pediatric and hematologic protocols. A prospective survey was carried from November 2013 to January 2014 out in 14 medical centers in Auvergne. This clinical audit was based on the HAS (national healthcare authority) framework and used as a reference regional standards based on the MASCC Antiemetic Guidelines...
July 2016: Bulletin du Cancer
https://www.readbyqxmd.com/read/27161869/supportive-care-in-older-adults-with-cancer-an-update-of-research-in-2015
#18
REVIEW
Christopher B Steer
The motto of the Multinational Association for Supportive Care in Cancer (MASCC) is "supportive care makes excellent cancer care possible". This is especially important in the care of older adults with cancer. The use of geriatric assessment in this patient population enables targeted supportive care interventions to work alongside appropriate anticancer therapy. It is the opinion of this author that geriatric oncology is mostly about the provision of streamlined, appropriate supportive care. There are many facets of supportive care of patients with cancer that are important regardless of age...
September 2016: Journal of Geriatric Oncology
https://www.readbyqxmd.com/read/27137212/abstracts-of-the-mascc-isoo-2016-annual-meeting
#19
(no author information available yet)
No abstract text is available yet for this article.
June 2016: Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer
https://www.readbyqxmd.com/read/27134539/assessing-prescribing-patterns-for-the-prevention-of-chemotherapy-induced-nausea-and-vomiting-in-the-national-center-for-cancer-care-and-research
#20
Manal Zaidan, Lana Soufi, M Hafeez, M Abdelwahid, Kakil I Rasul
PURPOSE: Chemotherapy is the mainstay of cancer treatment; however, chemotherapy treatment may cause nausea and vomiting, which could cause 25-50% of patients to consider delaying or refusing further cancer treatment. Chemotherapy-induced nausea and vomiting (CINV), can be prevented in 70-80% of patients with evidence-based anti-emetic regimen. The purpose of this study is to assess prescribing patterns with regard to prevention of CINV, in the national center for cancer care and research (NCCCR), and develop and implement a standardized evidence-based guideline for the management of CINV...
September 2015: Saudi Pharmaceutical Journal: SPJ: the Official Publication of the Saudi Pharmaceutical Society
keyword
keyword
17976
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"